Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Senores Pharmaceuticals Ltd

NSE: SENORES · BSE: 544319 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹1,355.20
Market cap: ₹6,241 Cr
Revenue (annual): ₹632.6 Cr
Net profit (annual): ₹115.4 Cr
P/E (TTM): 49.4×Sector 50.4×
Promoter holding: 45.82%+0.00% QoQ
FII holding: 6.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 2 Annual General Meeting 2 Price Movement Clarification 1 Other Announcement 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

27 Jul 2026 15:17 IST NSE

Financial ResultsAlfa Alert

Senores Pharmaceuticals Q1 FY27 Results: Net Profit ₹30.4 Cr, Up 43.4% YoY

Senores Pharmaceuticals Ltd reported revenue from operations of ₹180.2 Cr (+35.9% YoY) and net profit of ₹30.4 Cr (+43.4% YoY) for Q1 FY27.

Key figure: Net profit ₹30.4 Cr · +43.4% YoY

Open full results → Read the filing ↗

14 May 2026 14:10 IST NSE

Financial Results

Senores Pharmaceuticals Q4 FY26 Results: Net Profit ₹36.7 Cr, Up 103.9% YoY

Senores Pharmaceuticals Ltd reported revenue from operations of ₹175.2 Cr (+53.4% YoY) and net profit of ₹36.7 Cr (+103.9% YoY) for Q4 FY26.

Key figure: Net profit ₹36.7 Cr · +103.9% YoY

Open full results → Read the filing ↗